DE69312502D1 - Veränderung von polypeptiden - Google Patents

Veränderung von polypeptiden

Info

Publication number
DE69312502D1
DE69312502D1 DE69312502T DE69312502T DE69312502D1 DE 69312502 D1 DE69312502 D1 DE 69312502D1 DE 69312502 T DE69312502 T DE 69312502T DE 69312502 T DE69312502 T DE 69312502T DE 69312502 D1 DE69312502 D1 DE 69312502D1
Authority
DE
Germany
Prior art keywords
polypeptide
polypeptides
change
unaltered
biologically functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69312502T
Other languages
English (en)
Other versions
DE69312502T2 (de
Inventor
Katherine Varvill
Richard Pickersgill
Grahame Gould
Peter Goodenough
Bevan Mosely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of DE69312502D1 publication Critical patent/DE69312502D1/de
Publication of DE69312502T2 publication Critical patent/DE69312502T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462Lysozyme (3.2.1.17)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69312502T 1992-09-28 1993-09-28 Veränderung von polypeptiden Expired - Fee Related DE69312502T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9220418A GB2273931A (en) 1992-09-28 1992-09-28 Mutant polypeptides
PCT/GB1993/002026 WO1994008018A1 (en) 1992-09-28 1993-09-28 Alteration of polypeptides

Publications (2)

Publication Number Publication Date
DE69312502D1 true DE69312502D1 (de) 1997-09-04
DE69312502T2 DE69312502T2 (de) 1998-01-02

Family

ID=10722611

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69312502T Expired - Fee Related DE69312502T2 (de) 1992-09-28 1993-09-28 Veränderung von polypeptiden

Country Status (6)

Country Link
EP (1) EP0662135B1 (de)
JP (1) JPH08501939A (de)
AT (1) ATE155815T1 (de)
DE (1) DE69312502T2 (de)
GB (1) GB2273931A (de)
WO (1) WO1994008018A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES506955A0 (es) * 1980-11-10 1983-02-01 Genentech Inc Un procedimiento para producir un polipeptido antiviral.
EP0103395A3 (de) * 1982-08-17 1985-05-22 Biogen N.V. DNS-Sequenzen, rekombinante DNS-Moleküle und Verfahren zur Herstellung von rinderwachstumshormonähnlichen Polypeptiden, mit grosser Ausbeute
DE3643158A1 (de) * 1986-04-21 1987-11-19 Boehringer Mannheim Gmbh Gewebs-plasminogen-aktivator(tpa) - derivat und seine herstellung
JP2636862B2 (ja) * 1986-12-24 1997-07-30 武田薬品工業株式会社 組み換え型ヒトリンホトキシン
AU615194B2 (en) * 1987-03-12 1991-09-26 Amgen, Inc. Bovine growth hormone analogs
WO1991004270A1 (en) * 1989-09-20 1991-04-04 Commw Scient Ind Res Org Modified seed storage proteins

Also Published As

Publication number Publication date
EP0662135B1 (de) 1997-07-23
JPH08501939A (ja) 1996-03-05
GB9220418D0 (en) 1992-11-11
ATE155815T1 (de) 1997-08-15
DE69312502T2 (de) 1998-01-02
GB2273931A (en) 1994-07-06
WO1994008018A1 (en) 1994-04-14
EP0662135A1 (de) 1995-07-12

Similar Documents

Publication Publication Date Title
ES2031806T3 (es) Factor de permeabilidad vascular humano.
DE69635225D1 (de) Ozean fisch antifrost peptide als nahrungsmittelzusatz
DE69535948D1 (de) Von wd-40 abstammende peptide und ihre verwendung
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
IT1175508B (it) Un plasmide ricombinante, un microorganismo trasformante un segmento di polideossiribonucleotide, un procedimento per produrre una proteina biologicamente attiva e la proteina cosi' prodotta
EP0423224A4 (en) Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
ATE140962T1 (de) Dns-klone von menschlichem thrombomodulin
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
WO1996041877A3 (fr) Molecules polypeptidiques de stade pre-erythrocytaire du paludisme
ZA9410217B (en) Recombinant human thymopoietin proteins and uses therefor.
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
ATE155815T1 (de) Veränderung von polypeptiden
ATE109827T1 (de) Verfahren zur herstellung von peptiden, dazu zu verwendendes rekombinantes plasmid und mit diesem plasmid transformierte myelomzellen.
DE58905768D1 (de) Verfahren zur herstellung von zur rektalen und vaginalen anwendung geeigneten praeparaten biologisch aktiver peptide.
DE68923496T2 (de) Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression.
DE58907247D1 (de) Verfahren zur herstellung von dipeptiden mit c-terminalen nicht-proteinogenen aminosäuren.
DE58901435D1 (de) Verfahren zur herstellung von dipeptiden mit n-terminalen nichtproteinogenen aminosaeuren.
DE69121489D1 (de) In vitro-Behandlung von Fusionsproteinen
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE332392T1 (de) Verfahren zur herstellung rekombinanter, biologisch aktiver polypeptide
SE9100284D0 (sv) Novel peptide
ATE102950T1 (de) Verfahren zur herstellung von dipeptiden mit cterminalen nicht-proteinogenen aminosaeuren.
NO893572D0 (no) Lunge-overflateaktivt protein og beslektet polypeptid.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee